A vaccine developed by Novartis against meningitis B has been recommended for approval by the European Medicines Agency (EMA).The charity Meningitis UK called the 4CMenB vaccine jab the "biggest leap forward in the field" in 30 years.One in 10 people who develop meningitis B dies and around 1,870 people contract the disease every year in the UK.Children under five have the highest danger of con... Healthcare Today
Tuesday, 20 November 2012
Meningitis vaccine to get UK licence
A vaccine developed by Novartis against meningitis B has been recommended for approval by the European Medicines Agency (EMA).The charity Meningitis UK called the 4CMenB vaccine jab the "biggest leap forward in the field" in 30 years.One in 10 people who develop meningitis B dies and around 1,870 people contract the disease every year in the UK.Children under five have the highest danger of con... Healthcare Today
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment